| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 03/11/2004 | US20040049014 Production of non-immunogenic antibodies having strong affinity for a predetermined antigen |
| 03/11/2004 | US20040048798 Especially CTL polypeptides of specific sequences |
| 03/11/2004 | US20040048338 IL-17 receptor like molecules and uses thereof |
| 03/11/2004 | US20040048289 A protein specific to a magnetic particle membrane, DNA which encodes the protein and their uses |
| 03/11/2004 | US20040048277 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 03/11/2004 | US20040047883 For producing drug for stimulating the immune defences of the organism towards viral, parasitic or bacterial infections or cancerous antigens |
| 03/11/2004 | US20040047880 Component for vaccine |
| 03/11/2004 | US20040047879 Vaccine for treating hepatitis B and primary hepatocellular carcinoma |
| 03/11/2004 | DE10240894A1 Verstärkung der Resorption von Subtanzen über die Haut und Schleimhaut Enhance the absorption of Subtanzen through the skin and mucous membrane |
| 03/11/2004 | CA2495207A1 Modified transferin-antibody fusion proteins |
| 03/11/2004 | CA2494981A1 Production of multimeric fusion proteins using a c4bp scaffold |
| 03/10/2004 | EP1396542A2 Novel P-selectin ligand protein |
| 03/10/2004 | EP1396541A2 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
| 03/10/2004 | EP1395832A1 Methods for screening using interleukin soluble trimolecular complex |
| 03/10/2004 | EP1395656A2 Human drug metabolizing enzymes |
| 03/10/2004 | EP1395648A2 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms |
| 03/10/2004 | EP1395612A2 Modified recombinase |
| 03/10/2004 | EP1395605A2 Polymeric immunoglobulin fusion proteins that target low-affinity fcgamma receptors |
| 03/10/2004 | EP0868198B1 FCepsilon-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 03/10/2004 | CN1480466A Interfusion protein possessing dual functions of thrombolysis and anticoagulation as well as its application |
| 03/04/2004 | WO2004018681A2 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 03/04/2004 | WO2004018660A2 Novel lipases and uses thereof |
| 03/04/2004 | WO2004018511A2 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins |
| 03/04/2004 | WO2004018505A1 Akap84 and its use for visualization of biological structures |
| 03/04/2004 | WO2003103577A3 Novel recombinant anticoagulant proteins |
| 03/04/2004 | WO2003101173A3 Immunomodulatory constructs and their uses |
| 03/04/2004 | WO2003097871A8 Marker molecules associated with lung tumors |
| 03/04/2004 | WO2003072787A3 Method for detection of leptin receptor ligands |
| 03/04/2004 | WO2003068822A3 De-immunized (poly)peptide constructs |
| 03/04/2004 | WO2003055980A3 Il-17 like molecules and uses thereof |
| 03/04/2004 | WO2003050254A3 Novel chimeric tnf ligands |
| 03/04/2004 | WO2003008571A3 Chimeric chains that code for proteins that induce effects directed against viruses |
| 03/04/2004 | WO2002020762A8 Tnf receptor-like molecules and uses thereof |
| 03/04/2004 | US20040044188 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 03/04/2004 | US20040043935 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 03/04/2004 | US20040043927 Wound healing agents; anticancer agents; cardiovascular disorders |
| 03/04/2004 | US20040043457 Bifunctional fusion proteins with glucocerebrosidase activity |
| 03/04/2004 | US20040043425 Screening, detecting and/or prognosing respiratory system disorders; bronchodilator agents |
| 03/04/2004 | US20040043036 Binding to protein; adjustment concentration of calcium compound in cells |
| 03/04/2004 | CA2496952A1 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins |
| 03/04/2004 | CA2495198A1 Novel lipases and uses thereof |
| 03/04/2004 | CA2494974A1 Il-7 drug substance, composition, preparation and uses |
| 03/03/2004 | EP1394261A2 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
| 03/03/2004 | EP1394255A2 NANBV diagnostics and vaccines |
| 03/03/2004 | EP1394253A1 Anti-human ovarian cancer -anti-cd3 bispecific antibody |
| 03/03/2004 | EP1392846A2 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 03/03/2004 | EP1392831A2 Moraxella(branhamella) catarrhalis antigens |
| 03/03/2004 | EP1392826A2 Bifunctional fusion proteins with glucocerebrosidase activity |
| 03/03/2004 | EP1392725A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology |
| 03/03/2004 | EP1392717A1 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
| 03/03/2004 | EP1392359A2 Specific binding proteins and uses thereof |
| 03/03/2004 | EP1392357A2 Vaccine composition |
| 03/03/2004 | EP1392354A2 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds |
| 03/03/2004 | EP1392351A2 Chemokines as adjuvants of immune response |
| 03/03/2004 | EP1062224A4 Modified factor viii |
| 03/02/2004 | CA2069960C Bispecific heteroantibodies with dual effector functions |
| 02/26/2004 | WO2004016283A2 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 02/26/2004 | WO2004016282A1 Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 02/26/2004 | WO2004016212A2 Methods and compositions for targeting secretory lysosomes |
| 02/26/2004 | WO2004005335A3 Multimerised growth hormone fusion proteins |
| 02/26/2004 | WO2003083050A3 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 02/26/2004 | WO2003060071A3 Albumin fusion proteins |
| 02/26/2004 | WO2003016472A9 Hybrid interferon/interferon tau proteins, compositions and methods of use |
| 02/26/2004 | WO2002103002A3 Gene associated with leishmania parasite virulence |
| 02/26/2004 | WO2001074299A3 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 02/26/2004 | WO2001057175A3 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 02/26/2004 | US20040039185 Novel family member of inhibitor of apoptosis proteins |
| 02/26/2004 | US20040039166 Newly identified polypeptides and polynucleotides encoding such polypeptides referred to as inhibitor of apoptosis proteins (IAPL-3); use in diagnosis and in identifying compounds that may be agonists, antagonists |
| 02/26/2004 | US20040038886 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 02/26/2004 | US20040038876 For use in therapy and diagnosis |
| 02/26/2004 | US20040038339 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 02/26/2004 | US20040038235 A g-protein coupled receptor |
| 02/26/2004 | US20040037829 For immunoregulation and/or treatment of inflammation; muteins |
| 02/26/2004 | US20040037821 For expression of erythropoietin; genetic translocation; zinc finger motifs |
| 02/26/2004 | CA2494971A1 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 02/26/2004 | CA2493822A1 Methods and compositions for targeting secretory lysosomes |
| 02/26/2004 | CA2492930A1 Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 02/25/2004 | EP1391513A1 IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof |
| 02/25/2004 | EP1391509A1 Transformed silkworm producing human collagen |
| 02/25/2004 | EP1390505A2 Antigens of group b streptococcus and corresponding dna fragments |
| 02/25/2004 | EP1390503A2 Novel nucleic acid molecules |
| 02/25/2004 | EP1390468A2 Identification of essential genes of aspegillus fumigatus and methods of use |
| 02/25/2004 | EP1390410A1 Molecules for disease detection and treatment |
| 02/25/2004 | EP1390409A2 Monoclonal antibody neutralising cathepsin b activity and uses thereof |
| 02/25/2004 | EP1390403A2 Peptides derived from neural thread proteins and their medical use |
| 02/25/2004 | EP1390400A2 Pharmaceutical use for secreted bacterial effector proteins |
| 02/25/2004 | EP1390389A2 Cripto blocking antibodies and uses thereof |
| 02/25/2004 | EP1390384A2 Chromosome-based platforms |
| 02/25/2004 | EP1390074A1 Novel compositions and uses therefor |
| 02/25/2004 | EP0866861B1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 02/25/2004 | CN1477129A Recombinant vascular endothelial growth factor-diphtherin fusion protein, its preparation and application |
| 02/24/2004 | US6696557 Isolated nucleic acid comprising nucleotide sequence encoding extracellular domain of al-2 fused to immunoglobulin amino acid sequence |
| 02/24/2004 | US6696290 Genetic engineered multimeric proteins having extracellular domains of oncogenes which code transmembrane receptors, used as competitive antagonists or agonists of neuregulins; anticarcinogenic agents |
| 02/19/2004 | WO2004015113A2 Albumin-fused ciliary neurotrophic factor |
| 02/19/2004 | WO2004015112A1 Dns-constructs for the production of peptides |
| 02/19/2004 | WO2004015109A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use |
| 02/19/2004 | WO2004015057A2 Mucin-immunoglobulin fusion proteins |
| 02/19/2004 | WO2004014957A1 Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes |
| 02/19/2004 | WO2004014956A1 Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes |
| 02/19/2004 | WO2004014311A2 Nogo receptor antagonists |